McDonnell Boehnen Hulbert & Berghoff LLP partner Kevin Noonan, Ph.D. is quoted in a February 6, 2019 Bloomberg article entitled, “Court Rules Medical Diagnostic Can’t Be Patented, Leaving Biotech in ‘Legal Mess’.” A way to diagnose a severe neurological disorder can’t be patented as it covers a law of nature, a U.S. appeals court ruled Wednesday in a closely watched case that sought to clarify the patenting for medical diagnostic tests and instead has resulted in calls for Congress to step in. View the article